Publications

November 2016
Case

QuintilesIMS: Biosimilar Marketing in England

By: John A. Quelch and Emily C. Boudreau

QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details

Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England

Educators

Purchase

February 2005 (Revised November 2012)
Supplement

UAL 2004: Pulling Out of Bankruptcy (CW)

By: Daniel Baird Bergstresser, Kenneth A. Froot and Darren Robert Smart

UAL is a large air transportation company with roots that go back to the 1920s. As a legacy carrier, going back to before the 1978 deregulation of air transportation markets, United Airlines is burdened with cost structures that make it difficult to compete with newer... View Details

Keywords: Bankruptcy; Compensation; Costs; Loans; Reorganization; Restructuring; Financing and Loans; Insolvency and Bankruptcy; Compensation and Benefits; Air Transportation Industry; United States

Purchase

23 Apr 2014
HBS Case

Are Electronic Cigarettes a Public Good or Health Hazard?

When electronic cigarettes first appeared a little over a decade ago, they were hailed by many as a godsend: a tool to help smokers quit while mitigating the most harmful effects of tobacco. "The [e-cigarette] market is producing, at no View Details

Keywords: by Michael Blanding; Food & Beverage; Advertising

21 Jun 2021
News

A New Study Quantifies the Cost of Gender Bias: 6,500 Missed Opportunities for Women

Web

Strategy for Health Care Delivery - Institute For Strategy And Competitiveness

organizational models for transforming the way health care is delivered, measured, and reimbursed. Empowered with new insights and capabilities, you will return to your organization prepared to implement and oversee a value-based View Details

April 2014 (Revised January 2015)
Background Note

Note on Mobile Healthcare

By: John A. Quelch and Margaret L. Rodriguez

Delivering health care to the global population was a challenge. Health care costs accounted for ten percent of world GDP by 2013. In the U.S., health care costs were expected to top $3.1 trillion in 2014. New technologies, shortages of trained personnel and... View Details

Educators

Purchase

Web

Value Measurement for Health Care - Institute For Strategy And Competitiveness

with health care partners Increase operational efficiencies: Match clinical resources to clinical processes and improve resource utilization Optimize costs over the full cycle of care Manage reimbursement... View Details

Article

Drivers of the Variation in Prosthetic Implant Purchase Prices for Total Knee and Total Hip Arthroplasties

By: Derek A. Haas, Kevin J Bozic, Anthony M. DiGioia, Zirui Song and Robert S. Kaplan

Previous studies have documented wide variation in health-care spending and prices; however, the causes for the variation in supply purchase prices across providers are not well understood. The purpose of this study was to determine the drivers of variation in... View Details

Keywords: Costing; Cost Variation; Total Knee Arthroplasty; Total Hip Arthroplasty; Prosthetic Implant Cost; Health Care and Treatment; Cost Management; Health Industry; Health Industry

Research Summary

Clinical Trials as a setting for Health Policy and Management Research

The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details

01 Sep 2016
News

Case Study: Alumni Advice for a Health Care Startup

workers), who work as virtual health care assistants, handling everything from long-term care arrangements to transportation. Wellthy’s digital platform is designed as a consumer- friendly project management tool, and allows for... View Details

October 10, 2019
Article

The Case for the Public Option Over Medicare for All

By: Regina E. Herzlinger and Richard Boxer

How can the United States better control its health care costs and quality and still achieve universal coverage? The strongest choice is not Medicare for All, which would eliminate private insurance; it’s the public option, which would allow people to choose from... View Details

Keywords: Universal Health Coverage; Public Option; Medicare; Health Care and Treatment; Insurance; Cost Management; Quality; United States

Register to Read

January 2021
Article

COVID-19 Hasn't Been a Tipping Point for Value-Based Care, but It Should Be

By: Thomas W. Feeley

Four out of five health care provider organizations are suffering ongoing losses as a result of the COVID-19 pandemic, according to the recent NEJM Catalyst Insights Council survey on value-based payment and care. Yet Council members, who are still largely entrenched... View Details

Keywords: Value-based Health Care; Health Pandemics; Health Care and Treatment; Cost

June 2021
Article

Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative

By: Casey J. Allen, Jarrod S. Eska, Nikhil G. Thaker, Thomas W. Feeley, Robert S. Kaplan, Ryan W. Huey, Ching-Wei D. Tzeng, Jeffrey E. Lee, Steven J. Frank, Thomas A. Aloia, Vijaya Gottumukkala and Matthew H.G. Katz

We used national administrative data to assess multiple domains of value associated with enhanced recovery pathways for patients undergoing pancreatic surgery. Value metrics included in-hospital mortality, complication rates, length of stay (LOS), 30-day readmission... View Details

Keywords: Value-based Health Care; Health Care and Treatment; Analytics and Data Science; Outcome or Result; Measurement and Metrics; Performance Improvement

Article

Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment

By: Regina E. Herzlinger and Eugene Schneller

U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture... View Details

Keywords: Health Care; COVID-19; Regulation; Health Care and Treatment; Health Pandemics; Governing Rules, Regulations, and Reforms; Investment

July 2020
Article

Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany

By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern

Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details

Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany

17 Feb 2016
Blog Post

Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference

Over 650 people participated in the 13th annual Harvard Business School Health Care Club Conference, which took place on campus on Saturday, January 30th, 2016. The conference brought together students of business, medicine, government,... View Details

Keywords: Health Care

February 2019
Article

Who Benefits Most in Disease Management Programs: Improving Target Efficiency

By: Timothy Simcoe, Maryaline Catillon and Paul Gertler

Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details

Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry

Article

Defining, Measuring, and Improving Value in Spine Care

By: Robert S. Kaplan and Derek Haas

This chapter discusses how to measure and improve spine care outcomes and costs. Today’s commonly used outcome metrics, such as readmission and complication rates, are actually process and quality metrics. They are not the outcomes, such as improvement in pain and... View Details

Keywords: Spine Care; Outcomes Measurement; Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Measurement and Metrics; Performance Improvement; Value